These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7590814)

  • 1. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
    Maini RN; Elliott MJ; Brennan FM; Williams RO; Chu CQ; Paleolog E; Charles PJ; Taylor PC; Feldmann M
    Immunol Rev; 1995 Apr; 144():195-223. PubMed ID: 7590814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TNF alpha for the therapy of rheumatoid arthritis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S63-6. PubMed ID: 7768056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA).
    Maini RN; Elliott MJ; Brennan FM; Feldmann M
    Clin Exp Immunol; 1995 Aug; 101(2):207-12. PubMed ID: 7648705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
    Elliott MJ; Maini RN; Feldmann M; Kalden JR; Antoni C; Smolen JS; Leeb B; Breedveld FC; Macfarlane JD; Bijl H
    Lancet; 1994 Oct; 344(8930):1105-10. PubMed ID: 7934491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
    Maini RN; Brennan FM; Williams R; Chu CQ; Cope AP; Gibbons D; Elliott M; Feldmann M
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S173-5. PubMed ID: 8391952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
    Williams RO; Mason LJ; Feldmann M; Maini RN
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2762-6. PubMed ID: 7908442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
    Camussi G; Lupia E
    Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
    Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR
    J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
    Elliott MJ; Feldmann M; Maini RN
    Int J Immunopharmacol; 1995 Feb; 17(2):141-5. PubMed ID: 7544768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody therapy for rheumatoid arthritis].
    Ishii T; Saeki Y
    Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
    Williams RO; Feldmann M; Maini RN
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9784-8. PubMed ID: 1409699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
    Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
    Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
    Elliott MJ; Maini RN; Feldmann M; Long-Fox A; Charles P; Bijl H; Woody JN
    Lancet; 1994 Oct; 344(8930):1125-7. PubMed ID: 7934495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis.
    Paleolog E
    Mol Pathol; 1997 Oct; 50(5):225-33. PubMed ID: 9497911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
    Lorenz HM; Antoni C; Valerius T; Repp R; Grünke M; Schwerdtner N; Nüsslein H; Woody J; Kalden JR; Manger B
    J Immunol; 1996 Feb; 156(4):1646-53. PubMed ID: 8568271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
    Barrera P; van der Maas A; van Ede AE; Kiemeney BA; Laan RF; van de Putte LB; van Riel PL
    Rheumatology (Oxford); 2002 Apr; 41(4):430-9. PubMed ID: 11961174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.